Zenith Drugs Share Price Today | Stock Price & Zenith Drugs Share Screener
Track the current Zenith Drugs share price and stock price live with TickJournal's free stock screener. Check ZENITHDRUG 52-week chart for the annual price range and momentum. Use the Zenith Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Zenith Drugs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Zenith Drugs Share Price Chart
Track the current stock price of Zenith Drugs with an interactive chart. Analyse ZENITHDRUG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Zenith Drugs stock quote in one place.
Zenith Drugs Company Profile - Fundamental Screener
Screen Zenith Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENITHDRUG shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0QWN01013.
Company Details
Classification
Identifiers and Leadership
Zenith Drugs Balance Sheet Screener
Screen ZENITHDRUG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2024, total assets were ₹135, up from ₹98 in 2023.
Latest statistics put total assets at ₹135 and shareholder funds at ₹62, with a leverage ratio of 0.63.
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
Assets |
|||
| Total Assets | 135 | 98 | 69 |
| Current Assets | 113 | 84 | 54 |
| Fixed Assets | 11 | 12 | 11 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 9 | 9 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 62 | 18 | 12 |
| Share Capital | 17 | 0 | 0 |
| Reserves & Surplus | 45 | 17 | 12 |
Zenith Drugs Income Statement Screener - Profit & Revenue Analysis
Screen Zenith Drugs income statement and profit fundamentals. Analyze ZENITHDRUG quarterly results. Zenith Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2024-March, shows revenue of ₹134 and net profit of ₹10.
| Item | None-None | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
Revenue and Expenses | ||||
| Revenue | 0 | 134 | 116 | 93 |
| Expenses | 0 | 115 | 106 | 85 |
Operating Costs and Margins | ||||
| EBITDA | 0 | 19 | 10 | 8 |
| Operating Profit % | 0.00% | 13.00% | 8.00% | 7.00% |
| Depreciation | 0 | 1 | 1 | 1 |
| Interest | 0 | 3 | 2 | 2 |
Profit and Earnings | ||||
| Profit Before Tax | 0 | 13 | 7 | 4 |
| Tax | 0 | 4 | 2 | 1 |
| Net Profit | 0 | 10 | 5 | 3 |
| EPS | 0.00 | 5.63 | 122.02 | 78.22 |
Zenith Drugs Cash Flow Screener - Liquidity Fundamentals
Screen ZENITHDRUG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2024-March, operating activities used ₹13, and net cash flow was an inflow of ₹9.
Over the same period, investing activities provided ₹26 and financing activities used ₹5.
| Item | 2024-March | 2023-March | 2022-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | -13 | -5 | 5 |
| Investing Activities | 26 | 0 | -5 |
Financing and Net Cash | |||
| Financing Activities | -5 | 5 | 1 |
| Net Cash Flow | 9 | 0 | 1 |
Zenith Drugs Shareholding Pattern Screener
See Zenith Drugs shareholding pattern with promoter, FII, and DII holdings. Check Zenith Drugs promoter holding and ownership changes for ZENITHDRUG on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 69.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.73%, spread across 1,435 shareholders.
The shareholder count was 1,435 in 2026-Mar, compared with 1,544 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Sept | 2023-Sept |
|---|---|---|---|---|---|---|---|
Promoter Holding | |||||||
| Promoter Holding | 69.98% | 69.98% | 69.98% | 100.00% | 69.98% | 69.98% | 100.00% |
Institutional Investors | |||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | |||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.73% | 25.56% | 25.25% | 0.00% | 15.20% | 25.57% | 0.00% |
| Other Holding | 5.29% | 4.46% | 4.77% | 0.00% | 14.83% | 4.45% | 0.00% |
| Shareholder Count | 1,435 | 1,544 | 1,466 | 7 | 1,117 | 1,355 | 7 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Zenith Drugs. Zenith Drugs dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.50 | 0.70% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Zenith Drugs Stock Index Membership - Nifty & Sensex
See which indices include Zenith Drugs stock. Check ZENITHDRUG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Zenith Drugs Market Events Screener - Corporate Actions
Get Zenith Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Zenith Drugs stock events that may affect ZENITHDRUG share price, along with derivatives, futures and options activity and sector gainers.
7 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated July 23, 2026, with a record date of July 23, 2026.
It is followed by Quarterly Result Announcement dated May 29, 2026 and Quarterly Result Announcement dated November 14, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-23 | 2026-07-23 | Extraordinary General Meeting | NA | 5.84% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 16.69% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.67% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.76% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.06% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | 17.15% |
| 2024-09-17 | 2024-09-18 | Dividend | ₹ 0.50 /share | 107.89% |
Zenith Drugs Competitors Screener - Peer Stocks Comparison
Screen ZENITHDRUG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 435,863 | 36.83 | 61,674 | 12.69% | 11,565 | 38.95 |
| Divis Laboratories | 246,660 | 86.00 | 11,067 | 13.95% | 2,568 | 53.27 |
| Torrent Pharmaceuticals | 182,577 | 86.72 | 13,886 | 20.34% | 2,138 | 42.82 |
| Zydus Life Science | 115,910 | 25.96 | 27,658 | 17.64% | 5,026 | 51.33 |
| Cipla | 108,738 | 33.29 | 29,045 | 2.24% | 3,870 | 35.23 |
| Laurus Labs | 106,982 | 98.39 | 6,868 | 22.01% | 890 | 58.13 |
| Mankind Pharma | 103,418 | 50.84 | 14,636 | 14.85% | 1,938 | 59.40 |
| Dr Reddys Laboratories | 102,916 | 32.77 | 35,059 | 3.90% | 4,158 | 62.37 |
| Aurobindo Pharma | 96,203 | 26.41 | 34,145 | 5.56% | 3,503 | 49.32 |
| Lupin | 92,839 | 16.97 | 29,039 | 26.75% | 5,356 | 31.32 |
Zenith Drugs Company Announcements - News & Reports Screener
Screen ZENITHDRUG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.23. Market capitalisation stands at ₹76.31 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.